In a model of non-small cell lung cancer (NSCLC), HOXA9 was downregulated in lung tumor tissues when compared with matched non-tumor tissues, and HOXA9 overexpression inhibited cell migration and invasion which is also associated with the regulation of NF-κB activity [41]. Here, HOXA9 is linked to non-small cell lung carcinoma.